Tag Archives: DEA

Congress Is Back In Town… Little Has Changed – Update for September 12, 2023

We post news and comment on federal criminal justice issues, focused primarily on trial and post-conviction matters, legislative initiatives, and sentencing issues.

THEY’RE B-A-A-A-CK

Congress returned last week after its long August recess, ready to dig in and work on anything other than criminal justice reform.

equal220812

Last week, the right-of-center Americans For Tax Reform wrote all members of Congress urging passage of the EQUAL Act (S.524, H.R. 1062). Anti-tax advocate Grover Norquist argued that the crack/powder sentencing “unjustified disparity has resulted in the imprisonment of people who pose no greater threat than their counterparts convicted of cocaine offenses for far greater periods.”

Norquist argued that “it is a core, taxpayer-funded, government role to protect citizens from crime, and manage the criminal justice system. Taxpayers, and all Americans who cherish individual liberty, should take an interest that the criminal justice system is efficient and effective at protecting public safety, upholding the rule of law and property rights, while respecting the constitutional rights of citizens. Where there are failures, conservatives should work to fix the issue, just as we do in other areas of government.”

The Illinois Times last week reported that Sen Richard Durbin (D-IL), chair of the Judiciary Committee, said the EQUAL Act has failed to come up for a Committee vote “because of the opposition of a Republican member of the committee, whom he declined to identify.”

“One Republican wouldn’t go for 1-to-1, and we deal with consensus on the committee,” Durbin said. “I have him down lower – substantially lower than 18-to-1 – and I’m trying to get the other side that wants it to be 1-to-1 to accept a different figure. But that’s where we’ve been stuck for over a year. I’m going to do my best to get this moving.”

The unidentified Republican is undoubtedly Sen Charles Grassley (R-IA), ranking Republican on the Committee and co-sponsor with Durbin of a number of reform measures, most notably the First Step Act. Last December, Grassley’s proposal of 2.5-1 and nonretroactivity except with Dept of Justice consent in the so-called SMART Cocaine Sentencing Act (S.4116) killed EQUAL’s passage in the last Congress. Now, 9 months later, nothing seems to have changed.

Meanwhile, in the wake of last week’s recommendation by the Dept of Health and Human Services that marijuana be rescheduled from a Schedule I to a Schedule III drug, the White House last week asserted that President Biden has “always supported the legalization of marijuana for medical purposes,” she said. “He’s been very clear about that, where appropriate, consistent with medical and scientific evidence.

potscooby180713Marijuana Moment noted that “it’s not accurate to say that Biden has “always” backed cannabis reform. As a senator, he championed several pieces of legislation that ramped up the war on drugs.” Nevertheless, “if DEA goes along with HHS’s Schedule III recommendation, that would represent a major shift in federal marijuana policy, with an acknowledgment that cannabis is not a drug of high abuse potential and no medical utility.”

On the other hand, The Hill reported that advocates and policy experts say rescheduling marijuana under the Controlled Substances Act does not address the plethora of racial justice issues caused by current law.

“Rescheduling doesn’t address … the harm to marginalized communities,” said Natacha Andrews, executive director for the National Association of Black Cannabis Lawyers. “It doesn’t address the over-policing, it doesn’t address the immigration issues, it doesn’t address the access to federal services, and it’s not in alignment with what 38 states have done to regulate and legalize.”

“My initial reaction is that this is less than what the Biden administration promised specifically,” Cat Packer, director of drug markets and legal regulation at the Drug Policy Alliance, told The Hill.

MSNBC reported, “To be sure, moving marijuana to Schedule III wouldn’t dismantle the drug war or solve the host of problems needlessly caused by prohibition. Descheduling, or removing the plant from the government’s list of controlled substances, would make more sense and better align with Biden’s stated criminal justice views. Still, rescheduling would be historic, if only due to the historic stupidity that has kept cannabis on Schedule I to date.”

Americans for Tax Reform, Support for the EQUAL Act (September 8, 2023)

Illinois Times, Unjust Sentencing (September 7, 2023)

Marijuana Moment, Biden Has ‘Always Supported The Legalization Of Marijuana For Medical Purposes,’ White House Says Amid Rescheduling Recommendation (September 4, 2023)

The Hill, Marijuana rescheduling falls short of expectations on Biden (September 8, 2023)

MSNBC, What the federal ‘rescheduling’ of cannabis would (and wouldn’t) mean (September 4, 2023)

– Thomas L. Root

Biden FDA Delivers On Pot Rescheduling; Now for the DEA – Update for September 7, 2023

We post news and comment on federal criminal justice issues, focused primarily on trial and post-conviction matters, legislative initiatives, and sentencing issues.

FOOD AND DRUG ADMINISTRATION PROPOSES DROPPING MARIJUANA TO SCHEDULE III

marijuana221111The Dept of Health and Human Services’ Food and Drug Administration last week recommended that the Drug Enforcement Administration significantly loosen federal restrictions on marijuana, yet stopping short of proposing that pot be removed completely from the Controlled Substances Act.

HHS Assistant Secretary Rachel Levine wrote in a letter to the DEA that the FDA wants the drug moved from Schedule I to Schedule III under the CSA. As part of the review process, an HHS spokesperson told Politico last week, “HHS conducted a scientific and medical evaluation for consideration by DEA. DEA has the final authority to schedule or reschedule a drug under the Controlled Substances Act. DEA will now initiate its review.”

President Biden rolled out new initiatives on marijuana last October, pardoning all prior federal simple possession offenses (none of whom was in federal prison at the time) and asking HHS and the Attorney General to review how marijuana is scheduled based on its medical use. While the DEA is not required to follow HHS’s recommendation, it is unlikely that the agency will buck the President, who has made this a White House priority.

Reclassification is a step short of legalizing marijuana entirely, but it would mark a critical shift away from marijuana’s status as a Schedule I substance. Schedule I includes drugs with high risk of abuse that have no legitimate purpose, like heroin, LSD and ecstasy. Schedule III substances, such as ketamine, are seen as less dangerous and can be obtained legally with a prescription.

mario170628The effect of dropping marijuana to Schedule III might be a Sentencing Commission rewrite of USSG § 2D1.1 on marijuana offenses. Changing statutory minimums for marijuana set out in 21 USC § 841(b)(1), however, would require action by Congress.

DEA review will be complete within the next year.

Bloomberg, US Health Officials Urge Moving Pot to Lower-Risk Tier (August 30, 2023)

Politico, Slightly higher times: Biden administration moves to loosen weed restrictions (August 30, 2023)

– Thomas L. Root

‘Spirit Is Willing But…’ In Federal Drug Reform – Update for August 8, 2023

We post news and comment on federal criminal justice issues, focused primarily on trial and post-conviction matters, legislative initiatives, and sentencing issues.

NOTHING HAPPENING HERE…

vacation190905If Congress does not approve a new appropriations bill by September 30, the government could shut down. But as anyone who works in or with the federal government knows, the government pretty much shuts down every year for the month of August as legislators, agency heads and government employees leave town for vacations.

This leaves a number of issues important to federal defendants hanging. Two of those are cocaine and marijuana reform.

Before leaving town for the beach, Dept of Justice officials filed comments with the U.S. Sentencing Commission urging the Commission to adopt a number of priorities for the coming year. On the equivalency of powder and crack cocaine, the DOJ urged the Commission (1) to advocate that Congress for passage of the EQUAL Act (S.524 and H.R.1062) to remedy the current disparity between treatment of powder cocaine and cocaine base; and (2) to remind sentencing courts of “their obligation, when considering [18 USC § 3553(a)] sentencing factors, to consider the pharmacological similarities between powder and crack cocaine and whether it is appropriate to impose a variance consistent with the relevant base offense level for powder cocaine.”

You may recall that last October, President Biden directed that the Dept of Health and Human Services lead an effort to reclassify marijuana as something less than a Schedule I drug. That effort includes review by the Drug Enforcement Administration.

marijuana160818Pressed by Rep. Matt Gaetz (R-FL) during a July 27 oversight hearing on DEA, DEA Administrator Anne Milgram told the subcommittee that the agency has not been provided with a definite timeline to review marijuana’s classification. When Gaetz asked Milgram if she would request the timeline from the HHS, she said, “I will ask.”

The rescheduling of marijuana probably won’t be done until late next year. A rescheduling could possibly lead to changes in 21 USC § 841 as to punishment – if not conviction ¬– for marijuana.

DOJ, Letter to Sentencing Commission (July 31, 2023)

Forbes, DEA Head Pledges To Seek Federal Marijuana Rescheduling Review Timeline From HHS (July 31, 2023)

House Subcommittee on Crime and Federal Government Surveillance, Hearing (July 27, 2023)

– Thomas L. Root